Portal for patients

​Particular Sedatives Are Tied to Breathing Difficulties in Older COPD Patients

Caution is urged by study writer for experts prescribing benzodiazepines to such group of patients.

Particular Sedatives Are Tied to Breathing Difficulties in Older COPD Patients

An organization of sedatives that are broadly used raises the chance of serious breathing difficulties in older individuals with COPD, a new study says.

Avoid Xanax And Ativan

Benzodiazepines like alprazolam (Xanax) or lorazepam (Ativan) are usually prescribed to treat stress and insomnia, the study writer noted.

For the study, scientists analyzed the records of older adults suffering from COPD in Ontario. Those who'd been recently prescribed a such drugs had a 45 % increased risk of having breathing difficulties that needed outpatient treatment.

Such patients also had a 92% greater danger of needing to visit the ER for treatment of COPD or pneumonia, and were more inclined to be hospitalized for difficulties with breathing, as stated by the study published on April 17.

Patients Need To Be Constantly Monitored

The findings are consistent even after taking patients' COPD severity into consideration. Doctors, when prescribing such pills, must be cautious and monitor the side effects for respiratory tracts. Patients should also be observed for respiratory-associated symptoms.

Previous research found that 30 % of older Canadian citizens have been prescribed benzodiazepines.

While the research found an association of prescriptions that are sedative and bigger risk of breathing difficulties in senior adults with COPD, it failed to create a effect and cause relationship.

See also:

No comments

Application for treatment
MTEC 2019 (eng.-com)